What's New at GML?
Seasonal Respiratory Testing
Beginning October 2, 2023, Geisinger will re-launch seasonal small panel respiratory testing for influenza A/B, respiratory syncytial virus (RSV), and SARS-CoV-2.
Geisinger Epic Test Code = LAB2531, ABRCOVP
Performing Laboratories: GBH, GCMC, GJSH, GLH, GMC, GMCM, GSACH, GSWB, GWV, Grays Woods clinic, Pottsville clinic.
Testing focuses on:
- SYMPTOMATIC outpatients who are not high-risk according to CDC definitions.
- Some groups of asymptomatic inpatients to support infection prevention and bed management; i.e., discharges to long-term care or assisted living facilities and SARS-CoV-2 screening for hospital admissions without respiratory symptoms, including labor and delivery, behavioral health admissions, pre-transplant screening, and destination medicine.
For additional details, please see the Winter Respiratory Pathogen Testing Algorithm.
Welcome. Dr. Keri Donaldson, Vice Chair, Laboratory Medicine
Dr. Donaldson is an associate at Geisinger Medical Center in Danville, Pennsylvania, where he serves as the vice chair of Laboratory medicine and division chief of Clinical Pathology. In this role, he is responsible for medical oversight of all clinical pathology services for the Geisinger system, including clinical chemistry, immunology, toxicology, hematology, coagulation, transfusion service, apheresis, stem cell collection, point-of-care testing, flow cytometry, specimen processing, phlebotomy, and customer support.
He is the founder and CEO of SOVLD Health in Carlsbad, California, a company that specializes in designing novel technologies to identify an individual’s risk of disease such as their genetic risk assessment for opioid use disorder. From 2015 until coming to Geisinger, he also worked at Penn State Hershey Medical Center, where he most recently served as the medical director of the Institute for Personalized Medicine Clinical Laboratories.
Dr. Donaldson's major research interest is the application of predictability modeling on outcomes relative to patient care. Over the previous 10 years, he hasled or been involved in multiple successful efforts for novel test and intervention design at academic institutions, including University of Pennsylvania and Penn State University, as well as private industry at Prescient Medicine/SOLVD Health and Pacific Edge Diagnostics. During this time, he developed the first of its kind polygenetic combinatorial and environmental predictability model for drug response, advance analytical rare event detection algorithms to predict susceptible populations, and multiple factorial disease detection models to identify disease in patients earlier than previously possible. Portions of this work are now incorporated into standard disease screening practice (BRAF mutational testing and urinary tract infection detection), have driven new in vitro diagnostics (urine and coagulation testing), and are used to identify and guide practice at the payer level. The broadened impact of his research and development of new tests will assist in the precision delivery of care in health systems.
Welcome, Dr. Mark Mentrikoski
Dr. Mark Mentrikoski has joined the anatomic pathology staff in Danville, specializing in breast, gynecologic, and genitourinary pathology.
Dr. Mentrikoski received his MD from the University of Rochester, School of Medicine and Dentistry in Rochester, New York. He completed a residency in anatomic and clinical pathology at University of Virginia, Department of Pathology, Charlottesville, Virginia, and a fellowship in gynecologic pathology at Johns Hopkins Medical Institutes, Department of Pathology, Baltimore, Maryland.
He is board certified in anatomic and clinical pathology.
His research interests are endometrial and ovarian malignancies.
Welcome, Dr. Scott Peters
Scott Peters, DDS,has joined the anatomic pathology and dental staff in Wilkes-Barre. He will be based in the dentistry clinic in Wilkes-Barre, specializing in oral manifestations of systemic diseases. Dr. Peters is also an associate professor of oral and maxillofacial pathology at Geisinger Commonwealth School of Medicine in Scranton.
Dr. Peters is a graduate of the College of Dental Medicine at Columbia University, where he also completed a residency in oral and maxillofacial pathology.
Prior to joining Geisinger, Dr. Peters was an assistant professor of oral pathology at Columbia University College of Dental Medicine and served as the lab director for Columbia’s Oral Diagnostic Biopsy Service. The departments of dentistry and pathology are excited to welcome Dr. Peters on board and to offer this new service to our patients and communities.
Oral Biopsy Supply Requisition.